...
首页> 外文期刊>Muscle and Nerve >Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease.
【24h】

Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease.

机译:一个大家族患有Danon病的新型Lamp-2基因突变和成功的心脏移植治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Lysosome-associated membrane protein-2 deficiency (LAMP-2 deficiency), or Danon disease, is a rare X-linked lysosomal disease characterized by cardiomyopathy, vacuolar myopathy, and mental retardation. Less than 20 families with mutations of the Lamp-2 gene have been reported. We describe a family from Sardinia with eight affected patients (4 females and 4 males) and a novel mutation in exon 2 of the Lamp-2 gene (c.102_103delAG). Females developed isolated cardiomyopathy in adulthood, whereas males presented with cardiomyopathy, myopathy, and mental retardation before the age of 20 years. Cardiomyopathy was lethal in three females in their 40s and in three males before the age 20 years. One patient was successfully treated by heart transplantation with more than 5-year follow-up. This study demonstrates that Danon disease is a frequently fatal condition that is potentially treatable with heart transplantation.
机译:溶酶体相关膜蛋白2缺乏症(LAMP-2缺乏症)或Danon病是一种罕见的X连锁溶酶体病,其特征是心肌病,液泡性肌病和智力低下。据报道,有不到20个Lamp-2基因突变的家庭。我们描述了一个来自撒丁岛的家庭,有8名患者(4名女性和4名男性)和Lamp-2基因第2外显子的新突变(c.102_103delAG)。女性成年后发展为孤立型心肌病,而男性在20岁之前出现心肌病,肌病和智力低下。年龄在20岁之前的三名40多岁的女性和三名男性的心肌病致死。一名患者通过心脏移植成功治疗,并进行了5年以上的随访。这项研究表明,达农病是一种致命的疾病,可以通过心脏移植治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号